Fluorodeoxyglucose F18
Showing 1 - 25 of >10,000
GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)
Enrolling by invitation
- GEP-NET
- +3 more
-
Copenhagen, DenmarkRigshospitalet
Jan 24, 2023
Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized
Enrolling by invitation
- Breast Cancer
- +3 more
- 18F-FDG
- +2 more
-
Copenhagen, DenmarkRigshospitalet
Jan 18, 2023
Fluorodeoxyglucose F18 Trial in Ghent (Positron Emissie Tomografie - Computer Tomografie)
Recruiting
- Fluorodeoxyglucose F18
- Positron Emissie Tomografie - Computer Tomografie
-
Ghent, East-flanders, BelgiumUniversity Hospital Ghent
Jan 16, 2023
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte (procedure, other, device)
Recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Computed Tomography
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 3, 2023
Lung Carcinoma Trial in Philadelphia (Fludeoxyglucose F-18, Positron Emission Tomography, Computed Tomography)
Recruiting
- Lung Carcinoma
- Fludeoxyglucose F-18
- +3 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Mar 7, 2023
Mild Cognitive Impairment Trial in Winston-Salem ([11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan)
Enrolling by invitation
- Mild Cognitive Impairment
- [11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan
-
Winston-Salem, North CarolinaWake Forest School of Medicine
Dec 22, 2022
Breast Tumors, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Baku (68Ga-FAPI-46 PET/CT)
Recruiting
- Breast Neoplasms
- +3 more
- 68Ga-FAPI-46 PET/CT
-
Baku, AzerbaijanNational Centre of Oncology
Jun 21, 2022
Brain Glioblastoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18, Magnetic Resonance Imaging)
Completed
- Brain Glioblastoma
- Computed Tomography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,
Not yet recruiting
- Anatomic Stage II Breast Cancer AJCC v8
- +3 more
- Chemotherapy
- +4 more
- (no location specified)
Jan 24, 2023
Simultaneous Fluorodeoxyglucose Positron Emission Tomography and
Completed
- Visual Snow Syndrome
- simultaneous fluor-18 fluorodeoxyglucose (FDG) positron emission tomography with magnetic resonance imaging (PET/MRI)
- (no location specified)
Jan 26, 2023
Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Tumor in the Spine Trial in Houston (Computed Tomography,
Recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- Metastatic Malignant Neoplasm in the Spine
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 13, 2022
Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior Trial in Nashville (procedure, radiation, drug, other)
Completed
- Lung Carcinoma
- +2 more
- Computed Tomography
- +5 more
-
Nashville, Tennessee
- +1 more
Oct 17, 2022
Metastatic Malignant Tumor, Metastatic Malignant Tumor in the Bone Trial in Houston (Fludeoxyglucose F-18, Magnetic Resonance
Active, not recruiting
- Metastatic Malignant Neoplasm
- Metastatic Malignant Neoplasm in the Bone
- Fludeoxyglucose F-18
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
Histiocytosis Trial in Warsaw (fluorodeoxyglucose (18F-FDG))
Recruiting
- Histiocytosis
- fluorodeoxyglucose (18F-FDG)
-
Warsaw, Mazovian, PolandMother and Child Institute
Aug 2, 2022
Cigarette Smoker, Current Smoker, Former Smoker Trial in Palo Alto (Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18
Recruiting
- Cigarette Smoker
- +4 more
- Computed Tomography
- +3 more
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Jun 16, 2022
Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18,
Recruiting
- Breast Carcinoma
- +7 more
- Computed Tomography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 24, 2022
Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)
Not yet recruiting
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
- Bone Marrow Aspiration
- +10 more
-
Los Angeles, CaliforniaMelanie Ayala Ceja
Jul 10, 2023
Recurrent DLBCL, Refractory DLBCL Trial in Houston (Chemotherapy, Computed Tomography, Fludeoxyglucose F-18)
Completed
- Recurrent Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Chemotherapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2022
Rectal Cancer Trial in Wuhan (68Ga-FAPI-04, 18F-FDG)
Recruiting
- Rectal Cancer
-
Wuhan, Hubei, ChinaChina, Hubei Province
Aug 11, 2023
Advanced Cancer Trial in New York (FDG)
Suspended
- Advanced Cancer
- FDG
-
New York, New YorkWeill Medical College of Cornell University
Jan 28, 2022
Alzheimer, Memory Complaint, Memory Disorders Trial in Paris (procedure, radiation, biological)
Not yet recruiting
- Alzheimer Disease
- +2 more
- Electroencephalogram (EEG)
- +6 more
-
Paris, Ile De France, FranceHôpital Pitié Salpêtrière
Apr 7, 2023
Glioblastoma Trial in Los Angeles (Computed Tomography, Fludeoxyglucose F-18, Positron Emission Tomography)
Recruiting
- Glioblastoma
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Feb 2, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- +6 more
-
Los Angeles, California
- +3 more
Nov 16, 2022
Malignant Tumor Trial in Salt Lake City ([F-18]fluorodeoxyglucose, [F-18]fluorothymidine, Positron Emission Tomography)
Terminated
- Malignant Neoplasm
- [F-18]fluorodeoxyglucose
- +3 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Sep 20, 2021